Dahlman Rose Reiterates a 'Buy' on Molycorp (MCP); Adjusting Estimates for Short-Term, Still Optimistic Long-Term

Go back to Dahlman Rose Reiterates a 'Buy' on Molycorp (MCP); Adjusting Estimates for Short-Term, Still Optimistic Long-Term